Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Download
Faster access than browser!
 

Istradefylline

Index Istradefylline

Istradefylline (KW-6002) is a selective antagonist at the A2A receptor. [1]

7 relations: Adenosine A2A receptor, Antiparkinson medication, Caffeine, Dyskinesia, L-DOPA, Parkinson's disease, Receptor antagonist.

Adenosine A2A receptor

The adenosine A2A receptor, also known as ADORA2A, is an adenosine receptor, and also denotes the human gene encoding it.

New!!: Istradefylline and Adenosine A2A receptor · See more »

Antiparkinson medication

An antiparkinson medication is a type of drug which is intended to treat and relieve the symptoms of Parkinson's disease.

New!!: Istradefylline and Antiparkinson medication · See more »

Caffeine

Caffeine is a central nervous system (CNS) stimulant of the methylxanthine class.

New!!: Istradefylline and Caffeine · See more »

Dyskinesia

Dyskinesia refers to a category of movement disorders that are characterized by involuntary muscle movements, including movements similar to tics or chorea and diminished voluntary movements.

New!!: Istradefylline and Dyskinesia · See more »

L-DOPA

L-DOPA, also known as levodopa or L-3,4-dihydroxyphenylalanine is an amino acid that is made and used as part of the normal biology of humans, as well as some animals and plants.

New!!: Istradefylline and L-DOPA · See more »

Parkinson's disease

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.

New!!: Istradefylline and Parkinson's disease · See more »

Receptor antagonist

A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.

New!!: Istradefylline and Receptor antagonist · See more »

Redirects here:

C20H24N4O4, KW-6002.

References

[1] https://en.wikipedia.org/wiki/Istradefylline

OutgoingIncoming
Hey! We are on Facebook now! »